Aspirin 325 MG / citric acid 1000 MG / sodium bicarbonate 1916 MG Effervescent Oral Tablet... — RxCUI 1537012
RxNorm drug concept · Semantic branded drug
RxCUI 1537012
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1537012
Official nameAspirin 325 MG / citric acid 1000 MG / sodium bicarbonate 1916 MG Effervescent Oral Tablet [Bromo Seltzer Antacid Pain Reliever]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asASA 325 MG / Citric Acid 1000 MG / NaHCO3 1916 MG Effervescent Oral Tablet [Bromo Seltzer Antacid Pain Reliever]; BROMO SELTZER Antacid Pain Reliever 325 MG / 1000 MG / 1916 MG Effervescent Oral Tablet
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Aspirin Rectal: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Great question. A rectal suppository gets the medication into your system through the lining of the rectum rather than your stomach. This can be helpful if you're having trouble sw...
- Why would someone use a rectal suppository instead of just taking aspirin by mouth?
- First, check that the foil or plastic packet is fully sealed and undamaged before you open it — don't use it if it looks like it's already been opened. Once you open it, insert the...
- This is really important: aspirin — including the suppository form — should NOT be given to children or teenagers who have or are recovering from chicken pox or the flu. There is a...
🕸️ Concept Web — How Aspirin 325 MG / citric acid 1000 MG / sodium bi... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Aspirin 325 MG / citric acid 1000 MG / sodium bicarbonate 1916 MG Effervescent Oral Tablet [Bromo Seltzer Antacid Pain Reliever]
RxCUI 1537012 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Aspirin
1191IN -
Citric acid
21183IN -
Sodium bicarbonate
36676IN -
Aspirin / citric acid / sodium bicarbonate
689524MIN
-
Aspirin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Bromo Seltzer Antacid Pain Reliever
1312950BN
-
Bromo Seltzer Antacid Pain Reliever
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Aspirin / citric acid / sodium bicarbonate Effervescent Oral Tablet
1536466SCDF -
Aspirin / citric acid / sodium bicarbonate Oral Product
1153551SCDG -
Aspirin / citric acid / sodium bicarbonate Effervescent Oral Tablet [Bromo Seltzer Antacid Pain Reliever]
1537011SBDF -
Bromo Seltzer Antacid Pain Reliever Oral Product
1312954SBDG -
Effervescent Oral Tablet
1535727DF -
Oral Product
1151131DFG
-
Aspirin / citric acid / sodium bicarbonate Effervescent Oral Tablet
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Aspirin 325 MG / citric acid 1000 MG / sodium bicarbonate 1916 MG Effervescent Oral Tablet
1536675SCD -
Aspirin 325 MG
317300SCDC -
Citric acid 1000 MG
1536464SCDC -
Sodium bicarbonate 1916 MG
1536674SCDC -
Aspirin 325 MG / citric acid 1000 MG / sodium bicarbonate 1916 MG [Bromo Seltzer Antacid Pain Reliever]
1537010SBDC
-
Aspirin 325 MG / citric acid 1000 MG / sodium bicarbonate 1916 MG Effervescent Oral Tablet
Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Aspirin 325 MG / citric acid 1000 MG / sodium bicarbonate 1916 MG Effervescent Oral Tablet
SCD · 1536675 -
Aspirin 325 MG
SCDC · 317300 -
Citric acid 1000 MG
SCDC · 1536464 -
Sodium bicarbonate 1916 MG
SCDC · 1536674 -
Aspirin / citric acid / sodium bicarbonate Effervescent Oral Tablet
SCDF · 1536466 -
Aspirin / citric acid / sodium bicarbonate Oral Product
SCDG · 1153551
Brand-Name Concepts
-
Aspirin 325 MG / citric acid 1000 MG / sodium bicarbonate 1916 MG [Bromo Seltzer Antacid Pain Reliever]
SBDC · 1537010 -
Aspirin / citric acid / sodium bicarbonate Effervescent Oral Tablet [Bromo Seltzer Antacid Pain Reliever]
SBDF · 1537011 -
Bromo Seltzer Antacid Pain Reliever Oral Product
SBDG · 1312954 -
Bromo Seltzer Antacid Pain Reliever
BN · 1312950
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1537012 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 50201-0421-02 | 10 POUCH in 1 CARTON (50201-0421-2) / 2 TABLET, EFFERVESCEN... | Bromo Seltzer | Tower Laboratories Ltd | 2012-07-16 |
Observed labelers:
Tower Laboratories Ltd (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.